Rank | Holder | SharesFloat % | Change | Date reported |
---|---|---|---|---|
1 | Manufacturers Life Insurance Co | 5.36M (11.78%) | 39.01K Increased by +0.73% | Mar 31, 25 |
2 | FMR Inc | 5.27M (11.57%) | 143.00 Increased by +0.00% | Mar 31, 25 |
3 | Patient Capital Management, LLC | 4.13M (9.08%) | 290.74K Increased by +7.03% | Mar 31, 24 |
4 | Morgan Stanley - Brokerage Accounts | 3.92M (8.61%) | -297.89K Decreased by -7.60% | Mar 31, 25 |
5 | ArrowMark Colorado Holdings, LLC (ArrowMark Partners) | 3.82M (8.39%) | -599.00 Decreased by -0.02% | Sep 30, 23 |
6 | Patients Capital Management LLC | 2.71M (5.94%) | -1.15M Decreased by -42.49% | Mar 31, 25 |
7 | Timucuan Asset Management Inc/FL | 1.95M (4.28%) | 189.72K Increased by +9.74% | Mar 31, 25 |
8 | Massachusetts Financial Services Company | 1.85M (4.06%) | -694.09K Decreased by -37.56% | Mar 31, 25 |
9 | Vanguard Group Inc | 1.79M (3.92%) | 56.53K Increased by +3.16% | Dec 31, 23 |
10 | Bank of America Corp | 1.43M (3.13%) | -67.68K Decreased by -4.75% | Sep 30, 24 |
11 | Wasatch Advisors Inc. | 1.18M (2.59%) | -56.54K Decreased by -4.80% | Sep 30, 23 |
12 | Arrowstreet Capital Limited Partnership | 1.14M (2.51%) | -79.32K Decreased by -6.95% | Mar 31, 25 |
13 | HSBC Holdings PLC | 1.08M (2.38%) | -86.70K Decreased by -8.02% | Dec 31, 23 |
14 | Scheer, Rowlett & Assoc Invest Mgmt Ltd. | 1.02M (2.24%) | -197.53K Decreased by -19.35% | Mar 31, 25 |
15 | Pier Capital, LLC | 800.04K (1.76%) | 442.20K Increased by +55.27% | Mar 31, 25 |
16 | Silvercrest Asset Management Group LLC | 723.51K (1.59%) | 125.83K Increased by +17.39% | Sep 30, 24 |
17 | Barclays PLC | 672.44K (1.48%) | -244.83K Decreased by -36.41% | Sep 30, 23 |
18 | Ameriprise Financial Inc | 613.58K (1.35%) | 12.59K Increased by +2.05% | Sep 30, 24 |
19 | Penn Capital Management Company LLC | 568.53K (1.25%) | 568.53K Increased by +100.00% | Dec 31, 24 |
20 | EVR Research LP | 565.00K (1.24%) | 165.00K Increased by +29.20% | Mar 31, 24 |
Rank | Holder | SharesFloat % | Change | Date reported |
---|---|---|---|---|
1 | Morgan Stanley Inst Intl Advtg I | 2.81M (6.17%) | -265.07K Decreased by -9.44% | Mar 31, 25 |
2 | Morgan Stanley International Advantage | 2.81M (6.17%) | -265.07K Decreased by -9.44% | Mar 31, 25 |
3 | JHVIT Fundamental All Cap Core I | 2.12M (4.67%) | -55.15K Decreased by -2.60% | Mar 31, 25 |
4 | Patient Opportunity C | 2.00M (4.40%) | -896.52K Decreased by -44.75% | Mar 31, 25 |
5 | Fidelity Growth Compy Commingled Pl S | 1.94M (4.25%) | 0.00 Increased by 0.00% | Mar 31, 25 |
6 | Fidelity Growth Compy Commingled Pl O | 1.87M (4.12%) | 0.00 Increased by 0.00% | Aug 31, 24 |
7 | Fidelity® Growth Company | 1.62M (3.55%) | -1.28K Decreased by -0.08% | Nov 30, 23 |
8 | Fidelity Growth Company Fund | 1.51M (3.33%) | 0.00 Increased by 0.00% | Mar 31, 25 |
9 | Vanguard Explorer Inv | 1.38M (3.04%) | 0.00 Increased by 0.00% | Sep 30, 23 |
10 | MFS New Discovery Value I | 1.38M (3.04%) | -12.91K Decreased by -0.93% | Mar 31, 25 |
11 | Manulife US All Cap Equity F | 1.27M (2.79%) | -34.08K Decreased by -2.68% | Mar 31, 25 |
12 | Meridian Growth Legacy | 703.11K (1.54%) | 0.00 Increased by 0.00% | Sep 30, 23 |
13 | Fidelity® Series Canada | 640.63K (1.41%) | -1.69K Decreased by -0.26% | Nov 30, 23 |
14 | Fidelity Series Canada | 580.33K (1.27%) | -900.00 Decreased by -0.16% | Mar 31, 25 |
15 | JHancock Fundamental All Cap Core I | 534.58K (1.17%) | -11.59K Decreased by -2.17% | Mar 31, 25 |
16 | Manulife IM US All Cap Core | 534.58K (1.17%) | 62.27K Increased by +11.65% | Mar 31, 25 |
17 | Morgan Stanley Inst International Opp I | 534.54K (1.17%) | -47.89K Decreased by -8.96% | Jun 30, 24 |
18 | Morgan Stanley International Opportunity | 534.54K (1.17%) | -47.89K Decreased by -8.96% | Jun 30, 24 |
19 | Fidelity® Growth Company K6 | 522.38K (1.15%) | -10.04K Decreased by -1.92% | Nov 30, 23 |
20 | Fidelity® Series Growth Company | 497.51K (1.09%) | -500.00 Decreased by -0.10% | Nov 30, 23 |